(Q44124425)

30 November 2017

title

Statins are associated with a reduced risk of gastric cancer: a population-based case-control study (English)

1 reference

30 November 2017

5

Chun-Yuh Yang

1 reference

30 November 2017

Hui-Fen Chiu

1

1 reference

30 November 2017

Shu-Chen Ho

series ordinal

2

1 reference

30 November 2017

Chih-Ching Chang

series ordinal

3

1 reference

30 November 2017

Trong-Neng Wu

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

16 August 2011

1 reference

The American Journal of Gastroenterology

30 November 2017

published in

1 reference

30 November 2017

volume

106

1 reference

30 November 2017

issue

12

1 reference

30 November 2017

page(s)

2098-2103

1 reference

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins have biphasic effects on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins and risk of cancer: a systematic review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statin use and the risk of 10 cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins and cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Incidence of cancer and statin usage--record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statin use and cancer risk in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins and cancer: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins and the risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins and prostate cancer risk: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Cancer risk among statin users: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Efficacy and long-term adverse effect pattern of lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Epidemiological features of CKD in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statin use and the risk of breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Statins and osteoporosis: new role for old drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

HMG-CoA reductase inhibitors and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

The risk of stomach cancer in patients with gastric or duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Host-bacterial interactions in Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Analgesic use and the risk for progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Asia-Pacific consensus guidelines on gastric cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.277

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.277

1 reference

30 November 2017

1 reference